Re: Brandon A. Mahal, Mohammed Alshalalfa, Daniel E. Spratt, et al. Prostate Cancer Genomic-risk Differences Between African-American and White Men Across Gleason Scores. Eur Urol 2019;75:1038-40 (European Urology)
We read with great interest the study by Mahal et al [1] that reported differences in prostate cancer (PC) genomic risk between African-American and white men across Gleason scores. They found that African-American men with Gleason 6 disease at surgery had higher genomic risk scores than white men, whereas no racial differences in genomic risk scores were observed in Gleason 7-10 disease. We would like to point out several concerns.